A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)

Journal:

Clinical Infectious Diseases

Published:

2026-03-18

DOI:

10.1093/cid/ciag196

Affiliations:

12

Authors:

16

Go to article

Institutions	Authors	Share
Vanderbilt University Medical Center (VUMC), United States of America (USA)	2.000000	0.13
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)	2.000000	0.13
Harvard University, United States of America (USA)	2.000000	0.13
National Institutes of Health (NIH), United States of America (USA)	2.000000	0.13
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	1.000000	0.06
AIDS Clinical Trials Group (ACTG), United States of America (USA)	1.000000	0.06
University of Texas Medical Branch (UTMB), United States of America (USA)	1.000000	0.06
Merck - Rahway, United States of America (USA)	1.000000	0.06
University of the Witwatersrand, Johannesburg (Wits University), South Africa	1.000000	0.06
University College Dublin (UCD), Ireland	1.000000	0.06
Thai Red Cross Society, Thailand	1.000000	0.06
Weill Cornell Medicine, United States of America (USA)	1.000000	0.06

Interested in Clinical Sciences?